Class effect: dapagliflozin reduces cardiovascular and kidney events

Kidney Int. 2020 Feb;97(2):246-248. doi: 10.1016/j.kint.2019.08.035. Epub 2019 Oct 10.

Authors

Tania Salehi¹, P Toby Coates²

Affiliations

¹ Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
² Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Electronic address: Toby.Coates@sa.gov.au.

PMID: 31866112
DOI: 10.1016/j.kint.2019.08.035

No abstract available

Keywords: albuminuria; chronic kidney disease; diabetes; diabetic nephropathy.

Publication types

Comment

MeSH terms

Benzhydryl Compounds
Diabetes Mellitus, Type 2*
Glucosides
Humans
Kidney
Kidney Diseases*

Substances

Benzhydryl Compounds
Glucosides
dapagliflozin